Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.

Zhong ZL, Chen S.

Exp Diabetes Res. 2012;2012:350852. doi: 10.1155/2012/350852. Epub 2012 Oct 14.

PMID:
23304115
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study.

Hernestål-Boman J, Norberg M, Jansson JH, Eliasson M, Eriksson JW, Lindahl B, Johansson L.

Cardiovasc Diabetol. 2012 Dec 18;11:152. doi: 10.1186/1475-2840-11-152.

PMID:
23249721
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.

Nagi DK, McCormack LJ, Mohamed-Ali V, Yudkin JS, Knowler WC, Grant PJ.

Diabetes Care. 1997 Aug;20(8):1304-9.

PMID:
9250459
[PubMed - indexed for MEDLINE]
4.

Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study.

Varma R, Macias GL, Torres M, Klein R, Peña FY, Azen SP; Los Angeles Latino Eye Study Group.

Ophthalmology. 2007 Jul;114(7):1332-40. Epub 2007 Feb 16.

PMID:
17306879
[PubMed - indexed for MEDLINE]
5.

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.

Al-Hamodi Z, Ismail IS, Saif-Ali R, Ahmed KA, Muniandy S.

Cardiovasc Diabetol. 2011 Mar 18;10:23. doi: 10.1186/1475-2840-10-23.

PMID:
21414238
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Petrovic MG, Krkovic M, Osredkar J, Hawlina M, Petrovic D.

Clin Experiment Ophthalmol. 2008 Mar;36(2):168-72. doi: 10.1111/j.1442-9071.2007.01647.x. Epub 2008 Feb 13.

PMID:
18279437
[PubMed - indexed for MEDLINE]
7.

The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus.

Cilenšek I, Mankoč S, Globočnik Petrovič M, Petrovič D.

Mol Biol Rep. 2012 Jun;39(6):7061-7. doi: 10.1007/s11033-012-1537-8. Epub 2012 Feb 6.

PMID:
22311033
[PubMed - indexed for MEDLINE]
8.

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.

Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.

Wien Klin Wochenschr. 2005 Oct;117(19-20):707-10.

PMID:
16416371
[PubMed - indexed for MEDLINE]
9.

Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with Type 2 diabetes.

Liu L, Yu Q, Wang H, Zhang SX, Huang C, Chen X.

Diabet Med. 2006 Jun;23(6):643-8.

PMID:
16759306
[PubMed - indexed for MEDLINE]
10.

Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes.

Globocnik-Petrovic M, Hawlina M, Peterlin B, Petrovic D.

Ophthalmologica. 2003 May-Jun;217(3):219-24.

PMID:
12660488
[PubMed - indexed for MEDLINE]
11.

Association of C(-106)T polymorphism in aldose reductase gene with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.

Deng Y, Yang XF, Gu H, Lim A, Ulziibat M, Snellingen T, Xu J, Ma K, Liu NP.

Chin Med Sci J. 2014 Mar;29(1):1-6.

PMID:
24698671
[PubMed - indexed for MEDLINE]
12.

Fibrinolysis and diabetic retinopathy in NIDDM.

Mansfield MW, Grant PJ.

Diabetes Care. 1995 Dec;18(12):1577-81.

PMID:
8722054
[PubMed - indexed for MEDLINE]
13.

Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.

Wong TY, Poon P, Szeto CC, Chan JC, Li PK.

Kidney Int. 2000 Feb;57(2):632-8.

PMID:
10652041
[PubMed - indexed for MEDLINE]
Free Article
14.

Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.

Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K.

Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):786-91. doi: 10.1161/ATVBAHA.107.160168. Epub 2008 Jan 31.

PMID:
18239151
[PubMed - indexed for MEDLINE]
Free Article
15.

Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese.

Yang Y, Andresen BT, Yang K, Zhang Y, Li X, Li X, Wang H.

Exp Biol Med (Maywood). 2010 Oct;235(10):1204-11. doi: 10.1258/ebm.2010.010102. Epub 2010 Aug 26.

PMID:
20801867
[PubMed - indexed for MEDLINE]
16.

Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy.

Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y.

Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):21-6. doi: 10.1007/s00417-008-0915-3. Epub 2008 Aug 16.

PMID:
18709380
[PubMed - indexed for MEDLINE]
17.

Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus.

Crispim D, Fagundes NJ, dos Santos KG, Rheinheimer J, Bouças AP, de Souza BM, Macedo GS, Leiria LB, Gross JL, Canani LH.

Clin Endocrinol (Oxf). 2010 May;72(5):612-9. doi: 10.1111/j.1365-2265.2009.03684.x. Epub 2009 Aug 4.

PMID:
19681913
[PubMed - indexed for MEDLINE]
18.

K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Petrovic MG, Osredkar J, Saraga-Babić M, Petrovic D.

Clin Experiment Ophthalmol. 2008 Jul;36(5):468-72.

PMID:
18942221
[PubMed - indexed for MEDLINE]
19.

The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes.

Keen H, Lee ET, Russell D, Miki E, Bennett PH, Lu M.

Diabetologia. 2001 Sep;44 Suppl 2:S22-30.

PMID:
11587046
[PubMed - indexed for MEDLINE]
20.

Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.

Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.

Diabetes Metab. 2009 Jun;35(3):214-9. doi: 10.1016/j.diabet.2008.12.002. Epub 2009 May 5.

PMID:
19419896
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk